Alliances
Under the terms of the agreement, AbCellera and Lilly have committed to equally share initial development costs towards a product, after which Lilly will be responsible for all further development, manufacturing and distribution.
No financial terms were disclosed.
WindMIL Therapeutics and Cognate BioServices, Inc. announced they have entered an agreement to expand WindMIL’s clinical manufacturing capacity.
Mutual expertise drives innovations to address supply issues for vaccines for outbreak pathogens
As the coronavirus outbreak that causes COVID-19 escalates, biopharma companies and government agents are working quickly to develop and test a vaccine, although most estimates are it will take 12 to 18 months before it could get to market.
Amalia Adler-Waxman, vice president of Social Impact and Responsibility at Teva, told BioSpace that the company believes everyone should have access to essential medications, regardless of their geographic location.
Biogen and Sangamo Therapeutics announced a broad global licensing collaboration deal to develop and commercialize several compounds for a range of neurological and neuromuscular diseases.
In its announcement, Bicycle did not identify the cancer targets it will focus on in its collaboration with Genentech.
Via a five-year collaborative research pact, Harvard and Guangzhou Institute will split $115 million in research funding provided by China Evergrande Group.
Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy
PRESS RELEASES